Revenue Growth QoQ: guardionhealth.com (GHSI)

Corporate company logo of Guardion Health Sciences Inc. (GHSI)

Guardion Health Science is finalizing asset liquidation with transparent payouts, utilizing outsourced production to minimize its environmental footprint. Quarterly revenue growth rates confirm the current trend, with the metric value standing at -97.30. Simultaneously, Guardion Health Science is implementing eco-friendly packaging and monitoring the carbon footprint of its eye nutraceutical suppliers.

GHSI (Guardion Health Sciences, Inc.) Sales Growth QoQ history from 07/04/2022 to 10/19/2024

Analytical breakdowns and data insights for company Guardion Health Sciences, Inc. (GHSI)

- stock price and consensus target price:
Fundamental valuation:Guardion Health Science - GHSI
Mass-produced product of Guardion Health Sciences

Guardion Health Science (GHSI) possesses strong pricing power within the retinal nutraceuticals segment, enabling the company to maintain stable demand even amidst changes in drug costs. Quarterly revenue growth objectively measures the pace of sales expansion relative to the previous year, allowing investors to filter out management noise and assess real capital resilience through daily settlement dynamics.